Benvic Group Acquires Chemres, A Specialty US Compounder Focused On High-Performance Polymer Compounds Primarily For The Medical Sector

Benvic Group | August 17, 2021

Benvic announces the acquisition of the US-based Chemres, a leading provider of polymers, custom compounds and solutions for a variety of industries including medical, packaging, wire & cable.

Headquartered in Princeton (New Jersey) and with operations in Chesapeake (Virginia), Chemres is a specialty compounder with a strong position in the US contact lens market and it also has long-term customer relationships in the medical, wire & cable, and packaging industries. The company provides a high level of dedicated customer service as well as logistical and supply chain management expertise.

The combination with Chemres will allow Benvic to enter the US market and strengthen its exposure to the medical sector, allowing Benvic to become a key global supplier in this market. Benvic will combine its track record of supplying highly innovative solutions with the expertise of Chemres in the North American marketplace and its strong customer portfolio.

The acquisition of Chemres is the ninth 'add-on' acquisition since Benvic joined Investindustrial's portfolio in 2018. Among the others, in 2019 Benvic acquired Modenplast Medical, an Italian compounder, specializing in medical grade vinyl compounds and tubing extrusion. This was followed in 2020 with the acquisition of Luc & Bel, an Italian manufacturer which specializes in the design and manufacture of medical device components, and in 2021 with the acquisition of selected TPE and PP compounding assets from Celanese.

Luc Mertens, CEO of Benvic Group, said: "like Benvic, Chemres is a top performer in the compounding industry; out-performing competitors in growth, quality and client satisfaction. Our shared culture for performance and innovation will enable us to develop new business and technical synergies, and provide us with an exciting strategic opportunity in the US market. We look forward to work closely with the management team of Chemres in the coming years to expand our operations in North America and grow our polymer expertise across sectors and in particular in the medical sector. This acquisition is an important step forward in Benvic becoming a global leader in compounding."

Paul Keimig, CEO of Chemres, said: "Chemres is excited to partner with Benvic in order to accelerate our growth as well as provide additional value for our customers. Benvic's proven success in similar markets and the desire to use Chemres to grow its portfolio in the US market was key in our decision making process. With Benvic's vision to be the global leader, Chemres will accelerate its growth through organic and additional compounding acquisitions in the US market. Together, Benvic Group, through Chemres, will have unparalleled, global capabilities in the compounding world."

About Benvic Group
Founded in 1963 and a portfolio company of Investindustrial since 2018, Benvic Group is one of the leading suppliers of thermoplastic solutions in Europe. From idea to realization for its customers, Benvic develops, manufactures and markets innovative and highly customized thermoplastic solutions that are used in a wide range of applications, namely construction, medical, automotive, fluid transport, electro technical products, cables and food. Benvic has around 470 employees and currently operates a total of 8 production sites in France, Italy, Spain, Poland and UK. The group now exports to over 60 countries worldwide.

About Chemres
Headquartered in Princeton, NJ, Chemres is a global supplier of commodity and engineering resins. For nearly 25 years, Chemres has been servicing the medical, packaging and wire & cable markets using multiple manufacturing technologies. The company's ISO 13485:2016 compounding facility in Chesapeake, VA has recently added capacity to support the growing demand. Located near the Norfolk International Terminals (NIT), the site offers easy access for imports/exports and transfer of material from sea containers to railcar, bulk truck and various packaging options.


Chemicals in cleaning products can also enter our bodies by absorption through the skin or through ingestion of household dust and chemical residues left on dishes and cutlery. And when cleaning products are flushed down the drain, they can have a serious impact on aquatic ecosystems.


Chemicals in cleaning products can also enter our bodies by absorption through the skin or through ingestion of household dust and chemical residues left on dishes and cutlery. And when cleaning products are flushed down the drain, they can have a serious impact on aquatic ecosystems.

Related News

Agilis Collaborates with UL to Simplify Chemical Material and Ingredient Sourcing

Agilis Chemicals | October 01, 2020

Agilis Chemicals, a leading provider of commerce platform for the chemical industry, announced today a collaboration with UL, a leading safety science company. As part of the collaboration agreement, Agilis shall extend its flagship commerce platform to more than 4500 suppliers and hundreds of thousands of end-users of chemicals on the UL Prospector® platform, the largest network of chemical buyers and suppliers in the world.

Read More


Technipaq Partners with DuPont Tyvek and Freepoint Eco-Systems to Reduce and Recycle Medical Packaging Plastic Waste

Technipaq& DuPont & Tyvek | September 20, 2021

Technipaq Inc., a leading manufacturer of flexible sterilizable packaging solutions and Tyvek Authorized Converter, proudly announces a new partnership with DuPont Tyvek and recycling partner Freepoint Eco-Systems, designed to significantly build upon the company's ongoing sustainability and recycling efforts. Commencing on World Cleanup Day (Sept. 18, 2021), Technipaq will be able to effectively divert its mixed material plastic waste stream, containing Tyvek® and other plastic waste, generated during healthcare packaging manufacturing at its Crystal Lake, IL facility, away from landfills and to Freepoint, where it will be recycled for use in the production of new 'virgin-quality' plastics and fuels. "DuPont Tyvek has consistently taken a leadership role in forging interdisciplinary partnerships within the global healthcare packaging and manufacturing value chain, which is an increasingly important topic for our industry as we collectively seek to achieve more sustainable solutions and create a circular economy," said Brian Rosenburg, President and CEO, Technipaq. "We are excited and honored to play such a major role in helping make this a reality." "This represents yet another great multi-stakeholder partnership designed to build a waste-free, 'closed loop' healthcare packaging manufacturing environment," said John Richard, Vice President, DuPont Safety. "The healthcare industry requires a broad spectrum of plastics to manufacture packaging solutions for medical device, diagnostic and pharmaceutical products. Recyclability of healthcare packaging manufacturing waste is an increasingly important topic for the industry as it seeks to achieve sustainable solutions and a circular economy. Bringing a market leader such as Technipaq into this initiative marks a significant, positive step forward for our industry overall," added Richard. "Freepoint intends to recycle waste plastic that is usually very challenging to recycle and is typically headed for landfill or incineration," said Kat Doerr, Vice President of Origination, Freepoint Eco-Systems. "By converting plastic waste into reusable products, less oil is required to be extracted from the ground. This results in a more sustainable economy and a healthier planet." Freepoint aspires to divert 170 million pounds of plastic waste from landfills at each of its facilities on an annual basis—the equivalent of reducing GHG emissions from up to 55,000 cars per facility. Tyvek is mainly made of High-Density Polyethylene (HDPE) and is certified 100% recyclable, making it compatible with existing and emerging (advanced) recycling techniques. Due to its unique combination of properties, Tyvek® allows for the facilitation of packaging solutions—such as mono-material structures—that meet the sustainable design guidelines established by industry leaders such as Healthcare Plastics Recycling Council (HPRC), CEFLEX and RecyClass. Please visit Technipaq to learn more about the company's recent investments in new production technologies, expanded capabilities and products, and ongoing sustainability efforts through its partnership with Tyvek. About Technipaq An ISO 13485 certified manufacturer with more than 175,000 square feet of manufacturing and warehouse space, Technipaq specializes in coating, laminating, printing, slitting, sheeting, die-cutting, and fabricating high-quality, flexible sterilizable packaging solutions for the medical device, diagnostic, life science, and pharmaceutical industries. An Authorized Converter of DuPont Tyvek for medical packaging, the company maintains an extensive selection of custom stock laminates, manufactured in both peel-able and fusion seal format. Technipaq also specializes in converting Tyvek, foils, films, and surgical papers into high-barrier ETO, radiation and autoclave packaging. Since the company's inception nearly four decades ago by industry pioneer Phil Rosenburg, Technipaq has remained a leading single-stop supplier of customized packaging solutions for the medical industry. About DuPont DuPont is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at Investors can access information included on the Investor Relations section of the website at

Read More


Axalta will Acquire U-POL, a Leading Manufacturer of Automotive Aftermarket Paints, Protective Coatings, and Accessories

Axalta | July 08, 2021

Axalta Coating Systems, a leading global supplier of liquid and powder coatings, announced today that it has entered into definitive agreements to acquire U-POL Holdings Limited from Graphite Capital Management LLP and other holders for £428 million (approximately $590 million), subject to certain adjustments stated in the transaction's Sale and Purchase Agreements. U-POL, located in the United Kingdom, was founded in 1948 and is a leading manufacturer of repair and refinish products used mainly for automotive refinish and aftermarket protective applications. The company manufactures a wide variety of high-quality automotive refinishing goods and accessories, such as fillers, coatings, aerosols, adhesives, and paint-related products, as well as other automotive aftermarket protective coatings. U-POL distributes its products in over 100 countries and is well-known for its top brands, such as Raptor, Dolphin, and Gold. Axalta will accelerate the expansion of U-products POL's by increasing market access via Axalta's current sales and distribution channels while using U-distribution POL's networks to reach new clients with its Refinish Coatings portfolio. U-POL's talented global organization and its production facility and R&D lab in Wellingborough, England, bring huge capabilities to the company's commercial, manufacturing, and technology organizations, improving Axalta's capacity to serve customers worldwide. For the fiscal year 2021, U-POL expects net sales of about $145 million and adjusted EBITDA of around $38 million. Axalta expects substantial operational and commercial benefits throughout the merged global businesses. Annual operating savings and efficiency of about $10 million are anticipated to be fully achieved within 18 to 24 months after the transaction's completion. The entire consideration of approximately $590 million reflects an adjusted EBITDA multiple of about 12.5x for the full year 2021E, including run-rate operating synergies and efficiencies. Furthermore, the identified commercial efficiencies are expected to provide significant value over time. As a result, Axalta expects that the acquisition will be immediately accretive to adjusted EBITDA margin, excluding transaction-related costs. Axalta intends to fund the acquisition using cash on hand. About Graphite Capital Graphite is a specialized provider of private equity financing to UK-based mid-market companies. Graphite invests in both management buyouts and development capital opportunities. About Axalta Coating Systems Axalta is a global coating industry leader, offering clients innovative, colorful, beautiful, and long-lasting coating solutions. Our coatings are intended to prevent corrosion, improve productivity, and enhance durability in a wide range of applications, including light vehicles, commercial vehicles, and refinish applications, as well as electric motors, building facades, and other industrial uses. With over 150 years of expertise in the coatings industry, Axalta's global team is always looking for new ways to provide the best coatings, application systems, and technology to our more than 100,000 clients in over 130 countries.

Read More